Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.
复制标题
DOI:
10.1016/j.jaip.2016.12.027
复制
发表时间:
2017-07
期刊:
影响因子:
--
通讯作者:
Schleimer RP
中科院分区:
文献类型:
--
作者:
Stevens WW;Peters AT;Hirsch AG;Nordberg CM;Schwartz BS;Mercer DG;Mahdavinia M;Grammer LC;Hulse KE;Kern RC;Avila P;Schleimer RP
Aspirin exacerbated respiratory disease (AERD) comprises the triad of chronic rhinosinusitis with nasal polyps (CRSwNP), asthma, and intolerance to inhibitors of the cyclooxygenase-1 (COX-1) enzyme. The prevalence of AERD remains unclear and few studies have compared the clinical characteristics of patients with AERD to those with CRSwNP alone, asthma alone, or both CRSwNP and asthma. To determine the prevalence of AERD within a tertiary care setting, and to identify unique clinical features that could distinguish these patients from those with CRSwNP+Asthma or CRSwNP. Electronic medical records of patients at Northwestern in Chicago, Illinois were searched by computer algorithm and then manual chart review to identify 459 patients with CRSwNP alone, 412 with CRSwNP+Asthma, 171 with AERD, and 300 with asthma only. Demographic and clinical features including sex, atopy, and sinus disease severity were characterized. The prevalence of AERD among CRSwNP patients was 16%. AERD patients had undergone two-fold more sinus surgeries (p<0.001) and were significantly younger at the time of their first surgery (40±13 years) than CRSwNP patients (43±14 years, p<0.05). Atopy was significantly more prevalent in patients with AERD (84%) or asthma (85%) than in CRSwNP (66%, p<0.05). More patients with AERD (13%) had corticosteroid-dependent disease than CRSwNP+Asthma (4%, p<0.01) or asthma (1%, p<0.001). AERD is common among CRSwNP patients; even though AERD patients have CRSwNP and asthma, the clinical course of their disease is not the same as of patients who have CRSwNP and asthma but are tolerant to COX-1 inhibitors.
登录
查看更多内容
影响因子:
5.9
作者:
Dursun, Adile Berna;Woessner, Katharine A.;Stevenson, Donald D.
通讯作者:
Stevenson, Donald D.
影响因子:
14.2
作者:
Bochenek, Grazyna;Kuschill-Dziurda, Joanna;Nizankowska-Mogilnicka, Ewa
通讯作者:
Nizankowska-Mogilnicka, Ewa
影响因子:
14.2
作者:
Laidlaw, Tanya M.;Cutler, Anya J.;Boyce, Joshua A.
通讯作者:
Boyce, Joshua A.
影响因子:
5.9
作者:
Berges-Gimeno, MP;Simon, RA;Stevenson, DD
通讯作者:
Stevenson, DD
影响因子:
2.6
作者:
Awad, Osama G.;Lee, John H.;Graham, Scott M.
通讯作者:
Graham, Scott M.